S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Exelixis, Inc.

EXEL Healthcare
$41.24 +$0.07 (0.17%)
Market Cap: $10.71 B
Gurus Holding
11
Popularity Rank
#335
% of Shares Held
11.86%
Net Activity (Q4 2025)
+$180.93 M

Guru Ownership Trend

Guru Analysis for Exelixis, Inc. (EXEL)

Exelixis, Inc. (EXEL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 11 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.27 B.

Top institutional holders include Renaissance Technologies and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $180.93 M net inflow during the quarter.

Recent activity highlights Jeremy Grantham who increased their stake by 477.8%. Conversely, First Eagle Investment reduced exposure by 22.7%.

Key Holders

Top 5 by Value

$598.65 M
$40.57 M
$37.52 M
$31.75 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$255.32 M
Total Buy Value
New Buys 1
Additions 5
-$74.39 M
Total Sell Value
Reductions 5
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
5
Net Buyers
6

FAQs for Exelixis, Inc. (EXEL)

Major holders include Renaissance Technologies ($609.85 M), Cliff Asness ($598.65 M), Ray Dalio ($40.57 M). According to the latest reported data, 11 tracked investment managers collectively hold approximately 30.8 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $180.93 M, with 6 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 0 fully exited EXEL. The total reported sell value was $74.39 M.

Yes, 1 managers opened new positions in EXEL, and 5 increased their existing holdings. The total reported buy value was $255.32 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.95% Reduce -10.0% 13,914,043 $609.85 M Q4 2025
0.31% Add 48.8% 13,658,388 $598.65 M Q4 2025
0.15% Add 9.8% 925,712 $40.57 M Q4 2025
0.04% New Buy 855,980 $37.52 M Q4 2025
0.12% Reduce -13.1% 724,434 $31.75 M Q4 2025
0.08% Add 251.9% 343,533 $15.06 M Q4 2025
0.00% Add 228.4% 153,724 $6.74 M Q4 2025
0.89% Reduce -20.0% 84,000 $3.68 M Q4 2025
0.01% Add 477.8% 68,458 $3 M Q4 2025
0.01% Reduce -22.1% 62,622 $2.74 M Q4 2025
0.00% Reduce -22.7% 12,571 $550,987 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form